Impact of clinical pharmacist-led antimicrobial stewardship on antibiotic appropriateness, clinical outcomes, and antimicrobial consumption in hospital-acquired and ventilator-associated pneumonia: a randomized controlled trial
Abstract
Background Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are major drivers of inappropriate antimicrobial use and resistance in hospitals. Clinical pharmacist-led antimicrobial stewardship programs (ASPs) are promising interventions for optimizing antimicrobial prescriptions and combating antimicrobial resistance. Methods This prospective randomized controlled trial was conducted over 18 months (from April 2023 to October 2024) at a tertiary care hospital. Adult patients with HAP or VAP were randomized to receive either pharmacist-led ASP interventions (n = 366) or standard care (n = 334) in a clinical trial setting. The intervention comprised daily medication reviews, culture-guided optimization, therapeutic drug monitoring, duration optimization, adverse event monitoring, and multidisciplinary communication training. The primary outcome was an appropriate antimicrobial prescription on day three. Results The intervention group demonstrated significantly higher rates of appropriate antimicrobial prescriptions (77.6% vs. 60.8%; odds ratio [OR] = 2.26, 95% confidence interval [CI]: 1.65–3.09; p < 0.001). Clinical cure rates were higher in the intervention group (84.4% vs. 74.3%; OR = 1.86, 95% CI: 1.27–2.72; p = 0.001). The mean hospital length of stay was reduced by 2.83 days (14.64 ± 5.48 vs. 17.47 ± 7.22 days; p < 0.001). Total antimicrobial treatment duration decreased by 10.9% (11.98 ± 5.80 vs. 13.45 ± 6.12 days; p < 0.001).…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 366 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.